| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC36671-5mg |
|
883715-18-2 |
N-?Benzyllinolenamide - Glpbio |
0 | 需询价 | C25H37NO | |
| GC36670-10mg |
|
— |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA) - Glpbio |
0 | 需询价 | C2HF3O2 | |
| GC36670-5mg |
|
— |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA) - Glpbio |
0 | 需询价 | C2HF3O2 | |
| GC36670-1mg |
|
— |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA) - Glpbio |
0 | 需询价 | C2HF3O2 | |
| GC36668-5mg |
|
1185242-90-3 |
Mycophenolic acid D3 - Glpbio |
0 | 需询价 | C17H17D3O6 | |
| GC36668-1mg |
|
1185242-90-3 |
Mycophenolic acid D3 - Glpbio |
0 | 需询价 | C17H17D3O6 | |
| GC36666-100mg |
|
1421372-66-8 |
Mutated EGFR-IN-1 - Glpbio |
0 | 需询价 | C25H31N7O | |
| GC36666-50mg |
|
1421372-66-8 |
Mutated EGFR-IN-1 - Glpbio |
0 | 需询价 | C25H31N7O | |
| GC36666-10mg |
|
1421372-66-8 |
Mutated EGFR-IN-1 - Glpbio |
0 | 需询价 | C25H31N7O | |
| GC36666-5mg |
|
1421372-66-8 |
Mutated EGFR-IN-1 - Glpbio |
0 | 需询价 | C25H31N7O | |
| GC36666-2mg |
|
1421372-66-8 |
Mutated EGFR-IN-1 - Glpbio |
0 | 需询价 | C25H31N7O | |
| GC36666-10mM (in 1mL DMSO) |
|
1421372-66-8 |
Mutated EGFR-IN-1 - Glpbio |
0 | 需询价 | C25H31N7O | |
| GC36665-100mg |
|
1429180-08-4 |
Mutant IDH1 inhibitor - Glpbio |
0 | 需询价 | C25H34N6O3 | |
| GC36665-50mg |
|
1429180-08-4 |
Mutant IDH1 inhibitor - Glpbio |
0 | 需询价 | C25H34N6O3 | |
| GC36665-10mg |
|
1429180-08-4 |
Mutant IDH1 inhibitor - Glpbio |
0 | 需询价 | C25H34N6O3 | |
| GC36665-5mg |
|
1429180-08-4 |
Mutant IDH1 inhibitor - Glpbio |
0 | 需询价 | C25H34N6O3 | |
| GC36665-2mg |
|
1429180-08-4 |
Mutant IDH1 inhibitor - Glpbio |
0 | 需询价 | C25H34N6O3 | |
| GC36665-10mM (in 1mL DMSO) |
|
1429180-08-4 |
Mutant IDH1 inhibitor - Glpbio |
0 | 需询价 | C25H34N6O3 | |
| GC36664-100mg |
|
— |
Murepavadin TFA - Glpbio |
0 | 需询价 | C73H112N22O16.C2HF3O2 | |
| GC36664-50mg |
|
— |
Murepavadin TFA - Glpbio |
0 | 需询价 | C73H112N22O16.C2HF3O2 | |
小泰
|
010-60710855
|